{
  "docId": "019de070-c58c-706c-98f1-9eec26811648",
  "docSlug": "2a1e5b2d3a1cb25fe50abb3e75ae9bdf",
  "documentTitle": "Alkermes | Investor Day Presentation Deck | 144 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 132,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "agenda",
  "function": "front_matter",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-c58c-706c-98f1-9eec26811648/10",
  "deckHref": "/decks/019de070-c58c-706c-98f1-9eec26811648",
  "deckJsonHref": "/decks/019de070-c58c-706c-98f1-9eec26811648.json",
  "deckAnchorHref": "/decks/019de070-c58c-706c-98f1-9eec26811648#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.85,
        "x": 0.056,
        "y": 0.25
      },
      "kind": "list",
      "text": "VALUE CREATION: Innovation, Growth and Profitability — Blair Jackson\nALKERMES' NEW R&D MODEL: Optimizing for Success — Craig Hopkinson; Focus on Innovative Molecular Design — Markus Haeberlein\nONCOLOGY: Nemvaleukin alfa: Clinical Data Updates — Jessicca Rege; Nemvaleukin alfa: Preclinical Research — Heather Losey; Tumor-Targeted Split IL-12 Fusion Protein — Josh Heiber\nNEUROSCIENCE: Selective HDAC Inhibitors — Markus Haeberlein; Orexin 2 Receptor Agonists — Brian Raymer\nQ&A",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "17996644-ab71-428f-a348-56558fb53226",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.275,
        "x": 0.056,
        "y": 0.125
      },
      "kind": "title",
      "text": "Today's Agenda",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c76e36d-ba1a-40c5-91c4-d41f67fd12ac",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "b2cd865c-bb70-4af4-b94f-05dc16633a0f",
      "evidence": "The slide uses a structured list to present the agenda items.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 10,
      "beatId": "e69bd338-b010-4d79-bb12-76f71bdac0a3",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": "consultants-gambit-solution-approach",
      "evidence": "Slides 10-20 outline the company's value enhancement plan and strategic approach.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}